跳至主要内容
临床试验/EUCTR2013-000716-21-AT
EUCTR2013-000716-21-AT进行中(未招募)不适用

Pilot study to investigate the clinical effect of orally inhaled AP301 on treatment of primary graft dysfunction (PGD) in mechanically ventilated patients after primary lung transplantation

Apeptico Forschung und Entwicklung GmbH0 个研究点开始时间: 2013年4月30日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Being a male or female recipient on the AKH`s waiting list for primary single or double LuTX
  • PGD score = 1 within 72 hours after LuTX
  • Informed consent is available
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • History of clinically relevant allergies or idiosyncrasies to AP301 or any other inactive ingredient(s) of the investigational product
  • Postoperative ECMO support
  • Paediatric /adolescent recipients (< 18 years)
  • Lobar transplantation
  • Retransplantation
  • Combined solid organ transplants
  • Participation in other drug trials

研究者

相似试验